Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay

Greaney, 2021, Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection, Sci Transl Med, 13, 10.1126/scitranslmed.abi9915 Le, 2020, Evolution of the COVID-19 vaccine development landscape, Nat Rev Drug Discov, 19, 667, 10.1038/d41573-020-00151-8 Sahin, 2020 Polack, 2020, Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine, N Engl J Med, 383, 2603, 10.1056/NEJMoa2034577 Haas, 2021, Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data, Lancet, 397, 1819, 10.1016/S0140-6736(21)00947-8 Khoury, 2021, Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection, Nat Med, 27, 1205, 10.1038/s41591-021-01377-8 Muruato, 2020, A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation, Nat Commun, 11, 4059, 10.1038/s41467-020-17892-0 Kubo, 2020, Development of an automated chemiluminescence assay system for quantitative measurement of multiple anti-SARS-CoV-2 antibodies, Front Microbiol, 11, 628281, 10.3389/fmicb.2020.628281 Goto, 2021, Sustained neutralizing antibodies 6 Months following infection in 376 Japanese COVID-19 survivors, Front Microbiol, 12, 661187, 10.3389/fmicb.2021.661187 Wang, 2021, mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants, Nature, 592, 616, 10.1038/s41586-021-03324-6 Gilbert, 2021 Bergwerk, 2021, Covid-19 breakthrough infections in vaccinated health care workers, N Engl J Med, 10.1056/NEJMoa2109072 Planas, 2021, Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization, Nature, 596, 276, 10.1038/s41586-021-03777-9 Miyakawa, 2021, Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera, J Mol Cell Biol, 10.1093/jmcb/mjab050 Collier, 2021, Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2, Nature, 596, 417, 10.1038/s41586-021-03739-1 Kageyama, 2021, Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan, Clin Microbiol Infect, 10.1016/j.cmi.2021.07.042 Soffer, 2021, The association between obesity and peak antibody titer response in COVID-19 infection, Obesity (Silver Spring), 29, 1547, 10.1002/oby.23208 Watanabe, 2021, Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine, Diabetes Metab Res Rev, e3465 Kalimuddin, 2021, Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset, Med (New York, NY), 2, 682